Target intelligence / Profile preview

DNA (cytosine-5)-methyltransferase 1 mRNA 3' untranslated region (DNMT1 mRNA 3'UTR) (DNMT1 mRNA 3'UTR)

Target
DNMT1 mRNA 3'UTR
Molecular classification
RNA, Messenger RNA regulatory region
01

Overview

The 3' untranslated region (3'UTR) of the DNA methyltransferase 1 (DNMT1) messenger RNA is a critical regulatory segment that controls the expression of the DNMT1 enzyme. DNMT1 is the primary enzyme responsible for maintaining DNA methylation patterns during cell division, ensuring the inheritance of epigenetic marks (UniProt P26358). Dysregulation of DNMT1 is a hallmark of many cancers, where overexpression leads to the silencing of tumor suppressor genes through promoter hypermethylation. The 3'UTR contains binding sites for various microRNAs, such as the miR-148 family, which naturally regulate DNMT1 levels (Braconi et al., 2010). Therapeutic strategies have utilized antisense oligonucleotides (ASOs), such as MG98, to specifically bind this region and trigger mRNA degradation. This reduction in DNMT1 protein levels facilitates the reversal of epigenetic silencing, potentially restoring the expression of tumor suppressors. Clinical studies of MG98 have explored its efficacy in solid tumors and hematological malignancies (Stewart et al., 2003). However, targeting this region presents challenges, including the risk of global DNA hypomethylation and subsequent genomic instability. Despite these challenges, the DNMT1 mRNA 3'UTR remains a significant target for precision epigenetic therapy.

Other names
DNMT1 3'UTRDNA methyltransferase 1 mRNA 3'UTRMCMT mRNA 3'UTRDNA (cytosine-5)-methyltransferase 1 mRNA 3' untranslated region
02

Mechanism of action

Antisense oligonucleotides or microRNAs bind to the 3'UTR of DNMT1 mRNA to induce its degradation or inhibit its translation, thereby reducing DNMT1 protein levels and reversing aberrant DNA hypermethylation (Stewart et al., 2003; Braconi et al., 2010).

03

Biological functions

Regulation of mRNA stabilityRegulation of translationMaintenance of DNA methylationEpigenetic regulation
04

Disease associations

CancerMyelodysplastic syndromesAcute myeloid leukemiaSolid tumors
05

Safety considerations

Global DNA hypomethylationGenomic instabilityReactivation of silenced genesOff-target RNA binding
06

Interacting drugs

MG98

3 more in the full profile.

07

Biomarkers

DNMT1 mRNA levelsDNMT1 protein expressionGlobal DNA methylation levelsPromoter-specific methylation status

Beyond the preview

Go deeper on DNA (cytosine-5)-methyltransferase 1 mRNA 3' untranslated region (DNMT1 mRNA 3'UTR) (DNMT1 mRNA 3'UTR).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on DNA (cytosine-5)-methyltransferase 1 mRNA 3' untranslated region (DNMT1 mRNA 3'UTR) (DNMT1 mRNA 3'UTR).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call